Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention

BACKGROUND: The use of rifamycin antibiotics for TB prevention carries a risk of detrimental drug–drug interactions with concomitantly used ART. OBJECTIVES: To evaluate the interaction of the antiretroviral drug nevirapine in combination with 4 weeks of daily rifapentine and isoniazid for TB prevent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Podany, A T, Leon-Cruz, J, Hakim, J, Supparatpinyo, K, Omoz-Oarhe, A, Langat, D, Mwelase, N, Kanyama, C, Gupta, A, Benson, C A, Chaisson, R E, Swindells, S, Fletcher, C V
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879140/
https://ncbi.nlm.nih.gov/pubmed/33241266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa470
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars